Literature DB >> 115818

Mucopolysaccharidosis in a domestic short-haired cat--a disease distinct from that seen in the Siamese cat.

M E Haskins, P F Jezyk, R J Desnick, S K McDonough, D F Patterson.   

Abstract

A 10-month-old male domestic short-haired cat was examined because of progressive lameness, a broad face with depressed nasal bridge, small ears, corneal clouding, and multiple bone dysplasia. The cat excreted excessive amounts of glycosaminoglycan (a component of connective tissue) in its urine and had evidence of lysosomal storage of glycosaminoglycans in fibroblasts and neurons. Activity of alpha-L-iduronidase, a lysosomal enzyme involved in glycosaminoglycan degradation, was deficient in cultured fibroblasts and leukocytes. The mucopolysaccharidosis was distinct from that seen in Siamese cats in terms of the pathologic changes and the specific enzyme deficiency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115818

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I.

Authors:  Christian Hinderer; Peter Bell; Brittney L Gurda; Qiang Wang; Jean-Pierre Louboutin; Yanqing Zhu; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Mark E Haskins; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

2.  Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I.

Authors:  R M Shull; R J Munger; E Spellacy; C W Hall; G Constantopoulos; E F Neufeld
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

Review 3.  A review of gene therapy in canine and feline models of lysosomal storage disorders.

Authors:  Allison M Bradbury; Brittney L Gurda; Margret L Casal; Katherine P Ponder; Charles H Vite; Mark E Haskins
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-11       Impact factor: 5.032

4.  Morphologic and biochemical studies of canine mucopolysaccharidosis I.

Authors:  R M Shull; R G Helman; E Spellacy; G Constantopoulos; R J Munger; E F Neufeld
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

5.  Arylsulfatase B-deficient mucopolysaccharidosis in rats.

Authors:  M Yoshida; J Noguchi; H Ikadai; M Takahashi; S Nagase
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI.

Authors:  M M Sleeper; C M Kusiak; F S Shofer; P O'Donnell; C Bryan; K P Ponder; M E Haskins
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982

7.  The pathology of the feline model of mucopolysaccharidosis VI.

Authors:  M E Haskins; G D Aguirre; P F Jezyk; D F Patterson
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.